Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Anne Howard

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Clinical Medicine|July 29, 2023
Non-Hormonal ContraceptionSarah Anne Howard, Soumya Rahima Benhabbour
Research Square|December 3, 2025
First-in-line 3D-printed intravaginal ring for nonhormonal contraceptionSarah Anne Howard, Maimoona S Bhutta, Rima Janusziewicz, et al.
Drug Delivery and Translational Research|January 12, 2026
First-in-line 3D-printed intravaginal ring for nonhormonal contraceptionSarah Anne Howard, Maimoona S Bhutta, Rima Janusziewicz, et al.
Pharmaceutics|March 26, 2022
Effects of Injection Volume and Route of Administration on Dolutegravir In Situ Forming Implant PharmacokineticsJordan B Joiner, Jasmine L King, Roopali Shrivastava, et al.
Drug Delivery and Translational Research|May 27, 2025
First-in-line subcutaneous injectable for reversible, non-hormonal male contraceptionSarah Anne Howard, James K Tsuruta, Andres Prieto Trujillo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|July 29, 2023
Non-Hormonal ContraceptionSarah Anne Howard, Soumya Rahima Benhabbour
Research Square|December 3, 2025
First-in-line 3D-printed intravaginal ring for nonhormonal contraceptionSarah Anne Howard, Maimoona S Bhutta, Rima Janusziewicz, et al.
Drug Delivery and Translational Research|January 12, 2026
First-in-line 3D-printed intravaginal ring for nonhormonal contraceptionSarah Anne Howard, Maimoona S Bhutta, Rima Janusziewicz, et al.
Pharmaceutics|March 26, 2022
Effects of Injection Volume and Route of Administration on Dolutegravir In Situ Forming Implant PharmacokineticsJordan B Joiner, Jasmine L King, Roopali Shrivastava, et al.
Drug Delivery and Translational Research|May 27, 2025
First-in-line subcutaneous injectable for reversible, non-hormonal male contraceptionSarah Anne Howard, James K Tsuruta, Andres Prieto Trujillo, et al.
Pageof 1